No results for ‘’
Mankind Pharma Ltd
NSE: MANKIND BSE: 543904
₹2469.60
(4.13%)
Tue, 04 Aug 2026, 07:06 pm
Market Cap (in Cr)102005.87
PE Ratio49.97
Dividend0.04
Health Technology
Pharmaceuticals: Major
24.5KMankind Pharma Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 55000 | 2430 | 14 Oct 2025 |
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 55000 | 2430 | 14 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 42245 | 2440 | 13 Oct 2025 |
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 42245 | 2440 | 13 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE.- ODI | block | Buy | 55000 | 2434.1 | 09 May 2025 |
| COPTHALL MAURITIUS INVESTMENT LIMITED | block | Sell | 55000 | 2434.1 | 09 May 2025 |
| SOCIETE GENERALE | block | Buy | 120078 | 2082 | 10 Jul 2024 |
| AURIGIN MASTER FUND LIMITED | block | Buy | 48032 | 2082 | 10 Jul 2024 |
| CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED (ODI) | block | Buy | 48032 | 2082 | 10 Jul 2024 |
| CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD | block | Buy | 96063 | 2082 | 10 Jul 2024 |
Showing 1–10 of 103
Rows per page: